Skip to content
10-Q

Quarterly Report

Royalty Pharma plc RPRX

0001802768-25-000114

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 559.61M sh
Shares Diluted Q3 2025 · Sep 30, 2025 566.75M sh
Shares Diluted Q3 2025 · Sep 30, 2024 592.73M sh
Shares Diluted Q3 2025 · Sep 30, 2024 595.68M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $1.15B
Stock Repurchased Q3 2025 · Sep 30, 2024 $177.04M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $1.66B
Operating Cash Flow Q3 2025 · Sep 30, 2024 $2.03B
Long Term Debt Q3 2025 · Sep 30, 2025 $8.57B
Long Term Debt Q3 2025 · Dec 31, 2024 $6.61B
Short Term Debt Q3 2025 · Sep 30, 2025 $380M
Short Term Debt Q3 2025 · Dec 31, 2024 $997.77M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $938.94M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $929.03M
Stockholders Equity Q3 2025 · Sep 30, 2025 $9.62B
Stockholders Equity Q3 2025 · Jun 30, 2025 $9.5B
Stockholders Equity Q3 2025 · Dec 31, 2024 $10.34B
Stockholders Equity Q3 2025 · Sep 30, 2024 $10.26B
Stockholders Equity Q3 2025 · Jun 30, 2024 $9.75B
Stockholders Equity Q3 2025 · Dec 31, 2023 $10.08B
Current Liabilities Q3 2025 · Sep 30, 2025 $530.8M
Current Liabilities Q3 2025 · Dec 31, 2024 $1.25B
Total Liabilities Q3 2025 · Sep 30, 2025 $9.73B
Total Liabilities Q3 2025 · Dec 31, 2024 $7.88B
Current Assets Q3 2025 · Sep 30, 2025 $1.85B
Current Assets Q3 2025 · Dec 31, 2024 $1.8B
Total Assets Q3 2025 · Sep 30, 2025 $19.35B
Total Assets Q3 2025 · Dec 31, 2024 $18.22B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.67
Eps Diluted Q3 2025 · Sep 30, 2025 $1.28
Eps Diluted Q3 2025 · Sep 30, 2024 $1.21
Eps Diluted Q3 2025 · Sep 30, 2024 $1.44
Eps Basic Q3 2025 · Sep 30, 2025 $0.67
Eps Basic Q3 2025 · Sep 30, 2025 $1.29
Eps Basic Q3 2025 · Sep 30, 2024 $1.22
Eps Basic Q3 2025 · Sep 30, 2024 $1.45
Sga Expense Q3 2025 · Sep 30, 2025 $118.73M
Sga Expense Q3 2025 · Sep 30, 2025 $409.21M
Sga Expense Q3 2025 · Sep 30, 2024 $56.72M
Sga Expense Q3 2025 · Sep 30, 2024 $169.08M
Rd Expense Q3 2025 · Sep 30, 2025 $50.5M
Rd Expense Q3 2025 · Sep 30, 2025 $401.5M
Rd Expense Q3 2025 · Sep 30, 2024 $500K
Rd Expense Q3 2025 · Sep 30, 2024 $1.5M
Net Income Q3 2025 · Sep 30, 2025 $288.22M
Net Income Q3 2025 · Sep 30, 2025 $556.74M
Net Income Q3 2025 · Sep 30, 2024 $543.99M
Net Income Q3 2025 · Sep 30, 2024 $650.77M
Operating Income Q3 2025 · Sep 30, 2025 $427.16M
Operating Income Q3 2025 · Sep 30, 2025 $1.17B
Operating Income Q3 2025 · Sep 30, 2024 $735.07M
Operating Income Q3 2025 · Sep 30, 2024 $930.93M
Revenue Q3 2025 · Sep 30, 2025 $609.29M
Revenue Q3 2025 · Sep 30, 2025 $1.76B
Revenue Q3 2025 · Sep 30, 2024 $564.69M
Revenue Q3 2025 · Sep 30, 2024 $1.67B